Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection

Antiviral pre-exposure prophylaxis (PrEP) through daily drug administration can protect healthy individuals from HIV-1 infection. While PrEP was recently approved by the FDA, the potential long-term consequences of PrEP implementation remain entirely unclear. The aim of this study is to predict the...

Descripción completa

Detalles Bibliográficos
Autores principales: Duwal, Sulav, Schütte, Christof, von Kleist, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394807/
https://www.ncbi.nlm.nih.gov/pubmed/22808148
http://dx.doi.org/10.1371/journal.pone.0040382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394807/
https://www.ncbi.nlm.nih.gov/pubmed/22808148
http://dx.doi.org/10.1371/journal.pone.0040382

Ejemplares similares